fpl 57231 has been researched along with thromboxane a2 in 2 studies
| Studies (fpl 57231) | Trials (fpl 57231) | Recent Studies (post-2010) (fpl 57231) | Studies (thromboxane a2) | Trials (thromboxane a2) | Recent Studies (post-2010) (thromboxane a2) |
|---|---|---|---|---|---|
| 30 | 0 | 0 | 5,617 | 224 | 429 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heymann, MA; Schreiber, MD; Soifer, SJ | 1 |
| Clozel, M; Clyman, RI; Heymann, MA; Soifer, SJ | 1 |
2 other study(ies) available for fpl 57231 and thromboxane a2
| Article | Year |
|---|---|
Leukotriene antagonists attenuate thromboxane-inducible pulmonary hypertension.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Animals, Newborn; Blood Pressure; Cardiac Output; Chromones; Epoprostenol; Hypertension, Pulmonary; Lipoxygenase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Sheep; SRS-A; Thromboxane A2 | 1989 |
Thromboxane is not responsible for the high pulmonary vascular resistance in fetal lambs.
Topics: Animals; Benzofurans; Chromones; Female; Fetus; Pregnancy; Pulmonary Circulation; Sheep; SRS-A; Thromboxane A2; Thromboxane-A Synthase; Vascular Resistance | 1985 |